Article
Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.
Leukemia & lymphoma - 1 Jan 2023
Ma Guangyu, Gao Yuhuan, Jing Xiaotong, He Cuiying, Liu Haisheng, Wu Xiaolin, Gao Zhe, Li Yuan, Zhang Shengnan, Zhao Guimin
Abstract excerpt
In the current study, we assessed the relationship between mutations and the blood cell counts and early progression of patients with diffuse large-B cell lymphoma (DLBCL). A total of 109 patients with newly diagnosed DLBCL were included in this study. UBE2A mutation was only found in patients with bone marrow involvement. The mutations of ZNF608, SF3B1, DTX1, and NCOR2 were related to blood cell counts. NCOR2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.